Enterprise-Level Security for Small Business on Any Budget

What Is a Ketamine Troche?

This complete guide to ketamine troches covers everything patients need to know before starting treatment: how troches are made, how sublingual absorption works, what dosing looks like, what to expect during a session, and how to store your medication safely.

A ketamine troche (pronounced "tro-key") is a small compounded lozenge designed to dissolve under the tongue or between the cheek and gum. Produced by 503A specialty pharmacies on a per-prescription basis, each troche is formulated to match a specific patient's prescription. Troches are not commercially manufactured products pulled off a shelf. The active ingredient is the same ketamine used in clinical settings for treatment-resistant depression (TRD), anxiety, PTSD, and chronic pain.

Unlike IV ketamine administered at a clinic, troches allow patients to self-administer at home under a prescriber's supervision. Telehealth ketamine programs coordinate between prescribing providers and 503A compounding pharmacies to ship lozenges directly to patients. For a detailed look at how pharmacies produce them, see our guide on how troches are compounded.

In compounding pharmacy practice, "troche" and "lozenge" refer to the same dosage form: a small solid intended to dissolve in the mouth. Some pharmacies dispense rapid-dissolve tablets (RDTs) instead, but the buccal absorption mechanism is essentially the same.

Quick Reference: Common Questions

How long does a session last? The dissociative experience from a properly held buccal troche typically runs 45 to 90 minutes, with residual drowsiness for another hour. Onset begins roughly 10 to 20 minutes into the hold.

What is the difference between sublingual and buccal placement? Sublingual means under the tongue; buccal means between the cheek and gum. Both routes use mucosal tissue to absorb ketamine into the bloodstream. Our guide on sublingual vs. buccal placement covers the practical differences.

Are troches and lozenges the same thing? Yes. The terms are interchangeable in compounding practice.

How Sublingual Absorption Works

When a troche dissolves under your tongue, ketamine absorbs through the sublingual mucosa, the thin, highly vascularized tissue lining the floor of the mouth. This route bypasses first-pass hepatic metabolism, which is why sublingual and buccal bioavailability is higher than oral ingestion. Oral ketamine swallowed directly typically yields bioavailability in the 17-20% range. Sublingual absorption can reach 25-30% or higher depending on formulation, hold duration, and individual physiology. NIMH research has examined ketamine's rapid antidepressant effects in treatment-resistant patients, and absorption route is one reason troche technique matters so much.

The practical implication is direct: swallowing the troche during your hold window significantly reduces how much ketamine reaches your bloodstream. Keeping the dissolved material in contact with the mucosal lining for the full hold period is the single most important technique variable. For a deeper look at the pharmacokinetics, read our guide on how troche absorption works.

Several factors shape how well absorption works:

• Dissolution time: allowing the troche to dissolve fully over 15 to 30 minutes maximizes mucosal contact
• Saliva management: holding saliva under the tongue rather than swallowing preserves local concentration
• Mucosal health: avoiding food, drink, or smoking for at least one hour before administration supports healthy tissue
• Troche base: compounding pharmacies use different formulations (hard candy, soft lozenge, RDT) that affect dissolution rate; ask your pharmacy what base they use

The formulation choice matters more than most patients realize. A troche that dissolves too quickly may release ketamine before the mucosa can absorb it efficiently. One that dissolves too slowly may not release enough during the hold window. Your prescribing provider and pharmacy can advise on what to expect from your specific product. See our article on ketamine troche active ingredients to understand what goes into the formulation.

Dosing: How Prescribers Determine Your Troche Dose

Ketamine troche dosing is individualized. There is no universal starting point because the right dose depends on body weight, the condition being treated, prior ketamine exposure, and how your body metabolizes the medication. Prescribers typically begin at the lower end of a program's dose range and titrate upward across initial sessions rather than starting at a maximum.

Programs commonly structure initial treatment as a series of sessions over several weeks, assessing response before adjusting dose or frequency. Maintenance dosing, once a stable response is established, is often less frequent than the initial phase. For guidance on what starting doses typically look like, see our article on what dose to start with.

A few principles apply across most programs:

• Dose is expressed in milligrams (mg) of ketamine per troche
• Compounded troches can be prepared at specific doses not available in standard commercial products
• Session frequency during the initial phase is commonly 2 to 3 times per week
• Maintenance frequency typically drops to once weekly or less once a response is established
• Dose adjustments require a prescriber consultation; never self-adjust a controlled substance

If you are managing chronic pain rather than mood disorders, dosing protocols may differ. Our article on ketamine troche dosing for pain covers condition-specific context. For a broader look at how troches compare to other delivery formats in treatment outcomes, see troches vs. infusion outcomes.

What to Expect During a Session

The subjective experience of a ketamine troche session varies considerably between people and across sessions. A few consistent patterns show up in patient reports and clinical descriptions.

Onset begins roughly 10 to 20 minutes after placement, depending on how quickly the troche dissolves and individual absorption speed. The initial signal is often a mild numbing sensation in the mouth and tongue, followed by a gradual shift in perception. Most people notice some degree of dissociation, a feeling of emotional distance or detachment from the body or surroundings. At lower doses, this is subtle. At higher doses, perceptual changes become more pronounced. For a detailed breakdown of timing, see our onset, peak, and duration timeline.

Common sensations during a session include:

• Bitter or medicinal taste as the troche dissolves
• Mild numbness in the mouth and tongue
• Feelings of relaxation, heaviness, or drowsiness
• Mild visual or auditory changes at higher doses
• A sense of emotional distance or detachment from surroundings
• Occasional nausea, especially early in a treatment course

Most sessions last 60 to 90 minutes from placement to returning to baseline. Peak effects typically occur 30 to 60 minutes in, then gradually resolve. Residual drowsiness can persist for another hour. Plan your session for a time when you have at least 3 to 4 hours free with no obligations requiring focus or coordination.

The psychological content of sessions varies. Some people report vivid mental imagery or emotionally significant experiences. This variability is part of why many programs recommend an integration period after each session, a quiet window to reflect on what arose before returning to routine activity.

Side Effects and Safety

Ketamine troches are generally well-tolerated when used as prescribed, but side effects occur and should be anticipated. Knowing what to expect reduces anxiety and helps you recognize when something falls outside the normal range.

Common side effects include nausea (particularly in early sessions), dizziness, dissociation (an expected effect at therapeutic doses), drowsiness that may persist for an hour or more, and a transient rise in blood pressure. Most of these resolve within one to two hours. Nausea can often be reduced by fasting beforehand, staying hydrated, and using anti-nausea medication if your provider has prescribed it.

Less common but notable effects include urinary symptoms with frequent long-term use, oral mucosal irritation from the troche base, and psychological distress during or after a session if the dissociative experience is more intense than expected. If you experience significant distress, having a grounding plan prepared can help: a familiar playlist, a trusted person nearby, or a simple physical anchor like holding an ice cube.

Ketamine carries a risk of psychological dependence with recreational overuse. At the dosing frequencies typical of therapeutic programs, dependence risk is low but not zero. Stick to your prescribed schedule and discuss any urges to use outside of your program with your provider.

Who should not use ketamine troches without careful prescriber review: people with a history of psychosis, mania, active substance use disorder, uncontrolled hypertension, or hyperthyroidism. Ketamine also interacts with several medications, including CNS depressants, certain antidepressants, and thyroid medications. Review our guide on ketamine drug interactions before starting treatment and make sure your prescriber has your complete medication list. It is also worth reading our overview of troches and alcohol interactions before your first session.

Cost and Accessibility

For patients researching this approach, this complete guide to ketamine troches would be incomplete without addressing cost. Compounded troches are substantially less expensive per session than IV infusions or Spravato (esketamine nasal spray), which received FDA approval for treatment-resistant depression in 2019.

Most telehealth ketamine programs bundle prescription services, provider consultations, and pharmacy coordination into a monthly subscription. Individual troche costs from specialty pharmacies typically range from $1 to $15 per dose depending on dose strength, base, and pharmacy. Monthly program costs generally fall in the $100 to $400 range. Our detailed cost guide for ketamine troches breaks down what to expect from specific programs.

Insurance coverage for compounded ketamine troches remains limited. Neither Medicare nor most commercial insurers currently cover compounded ketamine as a standard benefit. Spravato may qualify for coverage with prior authorization, though in-office administration requirements add logistical burden. Our article on insurance coverage for ketamine explains what to ask your insurer.

Accessibility extends beyond cost. Troches are particularly valuable for patients in areas without a nearby ketamine clinic, patients with mobility limitations, and those who cannot take time off work for clinic visits. Telehealth programs have expanded access to this treatment significantly since 2020, though regulatory changes around telehealth prescribing of controlled substances have created some uncertainty. Our article on the FDA status of ketamine troches covers the regulatory picture in detail.

Storage, Shelf Life, and Traveling with Troches

Proper storage is essential to maintaining potency. Most compounded ketamine troches require refrigeration at 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius). Exposure to heat, light, or humidity can degrade the active ingredient. Your pharmacy will include storage instructions with your shipment. Follow them precisely and do not leave troches at room temperature for extended periods.

Shelf life for compounded troches typically runs 90 to 180 days from the compounding date when stored correctly, though this varies by pharmacy and formulation. Check the expiration date on your packaging before each session. Our troche storage guide covers optimal conditions in detail, including what to do if your troches were exposed to heat during shipping. For a specific breakdown of how long troches remain potent once dispensed, see how long prescription ketamine troches last in the refrigerator.

If you plan to travel with troches, there are specific documentation and transport considerations, especially for air travel and crossing state lines with a Schedule III controlled substance. Always carry the original pharmacy label and a copy of your prescription. Read our guide on traveling with ketamine troches before your trip to understand what documentation to carry and how to keep the medication at the correct temperature in transit.

If your troche is not dissolving as expected, do not assume the medication has failed. Formulation differences between batches and changes in mouth environment can affect dissolution rate. Our troubleshooting guide on what to do when a troche is not dissolving walks through common causes and fixes.